Endovascular management of infrainguinal disease

Journal of Endovascular Therapy

Volumn 13, Issue SUPPL. 2, 2006, Pages

  Lumsden, Alan B ^a   Das, Tony S ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b Presbyterian Heart Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CILOSTAZOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; STATINE DERIVATIVE;

ARTERY DISEASE; CONFERENCE PAPER; CONSENSUS; CRYOPLASTY; CRYOTHERAPY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG ELUTING STENT; ENDOVASCULAR THERAPY; INFRAINGUINAL DISEASE; INTERMITTENT CLAUDICATION; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MEDICAL SOCIETY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RISK REDUCTION; SYMPTOMATOLOGY;

EID: 33244477419     PISSN: 15266028     EISSN: None     Source Type: Journal    
DOI: 10.1177/15266028060130s203     Document Type: Conference Paper

References (8)

1. Criqui MH, Fronek A, Barrett-Connor E, et al. The prevalence of peripheral arterial disease in a defined population. Circulation. 1985;71:510-515.
2. Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381-386.
3. McDermott MM, Mehta S, Ahn H, et al. Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease. J Gen Intern Med. 1997;12:209-215.
4. Hirsch AT, Criqui MH, Treat-Jacobson D. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286:1317-1324.
5. Criqui MH, Fronek A, Klauber MR, et al. The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from noninvasive testing in a defined population. Circulation. 1985;71:516-522.
6. Kannel WB, McGee DL. Update on some epidemiologic features of intermittent claudication: the Framingham Study. J Am Geriatr Soc. 1985;33:13-18.
7. Fowkes FG, Housley E, Cawood EH, et al. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol. 1991;20:384-392.
8. Dormandy J, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000;31:S1-S296.